top of page
Developing therapeutics that harness the power of the nasal microbiome
Trench Therapeutics uses cutting edge research within the nasal microbiome to discover and develop live biotherapeutic products for the prevention and treatment of infectious and inflammatory diseases. By providing transformative alternatives to unnecessary antibiotic use, this innovative approach will address unmet medical needs and help end the vicious cycle of antibiotic escalation and resistance.
Co-founded by:
Cindy Liu, MD, MPH, PhD
David Harburger, PhD, JD
Prashant Girinath, PhD, JD
bottom of page